tm
Seeing Is Believing
tm
Seeing Is Believing
CRVS is currently covered by 5 analysts with an average price target of $21.12. This is a potential upside of $6.43 (43.77%) from yesterday's end of day stock price of $14.69.
Corvus Pharmaceuticals's activity chart (see below) currently has 47 price targets and 56 ratings on display. The stock rating distribution of CRVS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 85.83% with an average time for these price targets to be met of 649.9 days.
Highest price target for CRVS is $42, Lowest price target is $13, average price target is $27.5.
Most recent stock forecast was given by ROGER SONG from JEFFERIES on 22-Jan-2026. First documented stock forecast 05-Apr-2017.
Currently out of the existing stock ratings of CRVS, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2021
$42
$27.31 (185.91%)
$13
2 months 15 days ago
(22-Jan-2026)
2/3 (66.67%)
$16.48 (64.58%)
746
Buy Since 13-Oct-2025
$28
$13.99 (99.86%)
$16
2 months 16 days ago
(21-Jan-2026)
1/2 (50%)
$5.85 (26.41%)
99
Buy Since 02-Jan-2025
$27
$12.31 (83.80%)
$11
2 months 17 days ago
(20-Jan-2026)
3/4 (75%)
$5.59 (26.11%)
352
Buy Since 20-May-2025
$13
$-1.69 (-11.50%)
$11
5 months 8 days ago
(29-Oct-2025)
5/5 (100%)
$5.32 (69.27%)
179
Buy Since 27-May-2021
9 months 25 days ago
(12-Jun-2025)
6/6 (100%)
$2.36 (143.90%)
893
What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?
